Name: iTAg Tetramer/APC - HLA-A*02:01 PR-1 (VLQELNVTV)
Brand: MBL Life Sciences
Availability: InStock

Related products

Shop all

iTAg Tetramer/APC - HLA-A*02:01 NY-ESO-1 (SLLMWITQC)MBL Life Sciences$1,726.00

HLA-A*02:01 Negative Tetramer-PEMBL Life Sciences$1,610.00

HLA-A*02:01 Negative Tetramer-APCMBL Life Sciences$1,726.00

HLA-A*02:01 Negative Tetramer-BV421MBL Life Sciences$1,726.00

Reviews 0

No reviews have been added for this product.

Reviews

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications
Application	FC
Reactivity	Human
Conjugation	APC
Immunogen	PR-1
Peptide Sequence	VLQELNVTV
Class	Class I
Sequence Location	169-177
MHC Allele	A*02:01

Documents & Links for iTAg Tetramer/APC - HLA-A*02:01 PR-1 (VLQELNVTV)
Datasheet	iTAg Tetramer/APC - HLA-A*02:01 PR-1 (VLQELNVTV) Datasheet

Documents & Links for iTAg Tetramer/APC - HLA-A*02:01 PR-1 (VLQELNVTV)
Datasheet	iTAg Tetramer/APC - HLA-A*02:01 PR-1 (VLQELNVTV) Datasheet

Citations for iTAg Tetramer/APC - HLA-A*02:01 PR-1 (VLQELNVTV) – 1 Found

Morita, Yuriko; Heike, Yuji; Kawakami, Mami; Miura, Osamu; Nakatsuka, Shin-Ichi; Ebisawa, Michiko; Mori, Shin-Ichiro; Tanosaki, Ryuji; Fukuda, Takahiro; Kim, Sung-Won; Tobinai, Kensei; Takaue, Yoichi. Monitoring of WT1-specific cytotoxic T lymphocytes after allogeneic hematopoietic stem cell transplantation. International Journal Of Cancer. 2006;119(6):1360-7. PubMed

Reviews 0

Reviews

iTAg Tetramer/APC - HLA-A*02:01 PR-1 (VLQELNVTV)

Additional information

Reviews 0

iTAg Tetramer/APC - HLA-A*02:01 PR-1 (VLQELNVTV)

Additional information

Specifications

Specifications

iTAg Tetramer/APC - HLA-A*02:01 PR-1 (VLQELNVTV)

Additional information

iTAg Tetramer/APC - HLA-A*02:01 PR-1 (VLQELNVTV)

Additional information

Specifications

Specifications